A citation-based method for searching scientific literature

B N Atkinson, S C Bell, M De Vivo, L R Kowalski, S M Lechner, V I Ognyanov, C S Tham, C Tsai, J Jia, D Ashton, M A Klitenick. Mol Pharmacol 2001
Times Cited: 145



L G Harsing, Z Juranyi, I Gacsalyi, P Tapolcsanyi, A Czompa, P Matyus. Curr Med Chem 2006
Times Cited: 54




List of shared articles



Times cited

Synthesis and Biological Evaluation of N-((1-(4-(Sulfonyl)piperazin-1-yl)cycloalkyl)methyl)benzamide Inhibitors of Glycine Transporter-1.
Christopher L Cioffi, Shuang Liu, Mark A Wolf, Peter R Guzzo, Kashinath Sadalapure, Visweswaran Parthasarathy, David T J Loong, Jun-Ho Maeng, Edmund Carulli, Xiao Fang,[...]. J Med Chem 2016
6

Inhibition of glycine transporter-1 in the dorsal vagal complex improves metabolic homeostasis in diabetes and obesity.
Jessica T Y Yue, Mona A Abraham, Paige V Bauer, Mary P LaPierre, Peili Wang, Frank A Duca, Beatrice M Filippi, Owen Chan, Tony K T Lam. Nat Commun 2016
11


Sarcosine-Based Glycine Transporter Type-1 (GlyT-1) Inhibitors Containing Pyridazine Moiety: A Further Search for Drugs with Potential to Influence Schizophrenia Negative Symptoms.
Laszlo G Harsing, Julia Timar, Geza Szabo, Szabolcs Udvari, Katalin M Nagy, Bernadett Marko, Gabriella Zsilla, Andrea Czompa, Pal Tapolcsanyi, Akos Kocsis,[...]. Curr Pharm Des 2015
4

Multiple functions of neuronal plasma membrane neurotransmitter transporters.
Luca Raiteri, Maurizio Raiteri. Prog Neurobiol 2015
14

Allosteric modulators for the treatment of schizophrenia: targeting glutamatergic networks.
Frank S Menniti, Craig W Lindsley, P Jeffrey Conn, Jayvardhan Pandit, Panayiotis Zagouras, Robert A Volkmann. Curr Top Med Chem 2013
60

Atropisomeric 4-phenyl-4H-1,2,4-triazoles as selective glycine transporter 1 inhibitors.
Takashi Sugane, Takahiko Tobe, Wataru Hamaguchi, Itsuro Shimada, Kyoichi Maeno, Junji Miyata, Takeshi Suzuki, Tetsuya Kimizuka, Shuichi Sakamoto, Shin-ichi Tsukamoto. J Med Chem 2013
11


Lidocaine metabolites inhibit glycine transporter 1: a novel mechanism for the analgesic action of systemic lidocaine?
Robert Werdehausen, David Kremer, Timo Brandenburger, Lukas Schlösser, Janusz Jadasz, Patrick Küry, Inge Bauer, Carmen Aragón, Volker Eulenburg, Henning Hermanns. Anesthesiology 2012
31

Synthesis and biological evaluation of (4H-1,2,4-triazol-4-yl)isoquinoline derivatives as selective glycine transporter 1 inhibitors.
Takashi Sugane, Takahiko Tobe, Wataru Hamaguchi, Itsuro Shimada, Kyoichi Maeno, Junji Miyata, Takeshi Suzuki, Tetsuya Kimizuka, Takuma Morita, Shuichi Sakamoto,[...]. Bioorg Med Chem 2012
5

Interactions between glycine transporter type 1 (GlyT-1) and some inhibitor molecules - glycine transporter type 1 and its inhibitors (review).
Laszlo G Harsing, G Zsilla, P Matyus, K M Nagy, B Marko, Zs Gyarmati, J Timar. Acta Physiol Hung 2012
14


Synthesis and biological evaluation of 3-biphenyl-4-yl-4-phenyl-4H-1,2,4-triazoles as novel glycine transporter 1 inhibitors.
Takashi Sugane, Takahiko Tobe, Wataru Hamaguchi, Itsuro Shimada, Kyoichi Maeno, Junji Miyata, Takeshi Suzuki, Tetsuya Kimizuka, Atsuyuki Kohara, Takuma Morita,[...]. J Med Chem 2011
9


Recent progress in the discovery of non-sarcosine based GlyT1 inhibitors.
Scott E Wolkenberg, Cyrille Sur. Curr Top Med Chem 2010
29

Selective GlyT1 inhibitors: discovery of [4-(3-fluoro-5-trifluoromethylpyridin-2-yl)piperazin-1-yl][5-methanesulfonyl-2-((S)-2,2,2-trifluoro-1-methylethoxy)phenyl]methanone (RG1678), a promising novel medicine to treat schizophrenia.
Emmanuel Pinard, Alexander Alanine, Daniela Alberati, Markus Bender, Edilio Borroni, Patrick Bourdeaux, Virginie Brom, Serge Burner, Holger Fischer, Dominik Hainzl,[...]. J Med Chem 2010
95

Glycine transporter (GlyT1) inhibitors with reduced residence time increase prepulse inhibition without inducing hyperlocomotion in DBA/2 mice.
Karla Kopec, Dorothy G Flood, Maciej Gasior, Beth Ann W McKenna, Eva Zuvich, Justin Schreiber, Joseph M Salvino, John T Durkin, Mark A Ator, Michael J Marino. Biochem Pharmacol 2010
26

Pharmacological evaluation of a novel assay for detecting glycine transporter 1 inhibitors and their antipsychotic potential.
Daniela Alberati, Jean-Luc Moreau, Roland Mory, Emmanuel Pinard, Joseph G Wettstein. Pharmacol Biochem Behav 2010
16

Discovery of benzoylisoindolines as a novel class of potent, selective and orally active GlyT1 inhibitors.
Emmanuel Pinard, Daniela Alberati, Markus Bender, Edilio Borroni, Virginie Brom, Serge Burner, Holger Fischer, Dominik Hainzl, Remy Halm, Nicole Hauser,[...]. Bioorg Med Chem Lett 2010
7

Glycine transporter inhibitors as a novel drug discovery strategy for neuropathic pain.
Toshihiro Dohi, Katsuya Morita, Tomoya Kitayama, Naoyo Motoyama, Norimitsu Morioka. Pharmacol Ther 2009
76


Neurochemical and behavioral profiling of the selective GlyT1 inhibitors ALX5407 and LY2365109 indicate a preferential action in caudal vs. cortical brain areas.
Kenneth W Perry, Julie F Falcone, Matthew J Fell, John W Ryder, Hong Yu, Patrick L Love, Jason Katner, Kimberly D Gordon, Mark R Wade, Teresa Man,[...]. Neuropharmacology 2008
70

Discovery of benzoylpiperazines as a novel class of potent and selective GlyT1 inhibitors.
Emmanuel Pinard, Daniela Alberati, Edilio Borroni, Holger Fischer, Dominik Hainzl, Synèse Jolidon, Jean-Luc Moreau, Robert Narquizian, Matthias Nettekoven, Roger D Norcross,[...]. Bioorg Med Chem Lett 2008
23


Inhibitors of GlyT1 affect glycine transport via discrete binding sites.
Mario Mezler, Wilfried Hornberger, Reinhold Mueller, Martin Schmidt, Willi Amberg, Wilfried Braje, Michael Ochse, Hans Schoemaker, Berthold Behl. Mol Pharmacol 2008
46